333 related articles for article (PubMed ID: 31856691)
1. Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial.
Kim BJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kim HY; Kim EG; Kim S; Cha JK; Park MS; Nam HS; Kang DW;
Stroke; 2020 Mar; 51(3):931-937. PubMed ID: 31856691
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol versus aspirin in ischemic stroke with cerebral microbleeds versus prior intracerebral hemorrhage.
Park HK; Lee JS; Kim BJ; Park JH; Kim YJ; Yu S; Hwang YH; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Kwon SU; Hong KS;
Int J Stroke; 2021 Dec; 16(9):1019-1030. PubMed ID: 32664827
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.
Kim BJ; Lee EJ; Kwon SU; Park JH; Kim YJ; Hong KS; Wong LKS; Yu S; Hwang YH; Lee JS; Lee J; Rha JH; Heo SH; Ahn SH; Seo WK; Park JM; Lee JH; Kwon JH; Sohn SI; Jung JM; Navarro JC; Kang DW;
Lancet Neurol; 2018 Jun; 17(6):509-518. PubMed ID: 29778364
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
Hong KS; Kim BJ; Lee JY; Kwon SU;
Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial.
Kim BC; Youn YC; Jeong JH; Han HJ; Kim JH; Lee JH; Park KH; Park KW; Kim EJ; Oh MS; Shim Y; Lee JM; Choi YH; Park G; Kim S; Park HY; Yoon B; Yoon SJ; Cho SJ; Park KC; Na DL; Park SA; Choi SH
Stroke; 2022 Mar; 53(3):698-709. PubMed ID: 34781708
[TBL] [Abstract][Full Text] [Related]
6. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
[TBL] [Abstract][Full Text] [Related]
8. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.
Wong KSL; Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Himmelmann A; Kasner SE; Knutsson M; Ladenvall P; Minematsu K; Molina CA; Wang Y; Johnston SC;
Stroke; 2018 Jul; 49(7):1678-1685. PubMed ID: 29915123
[TBL] [Abstract][Full Text] [Related]
10. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y; Kimura K; Otsuka T; Toyoda K; Uchiyama S; Hoshino H; Sakai N; Okada Y; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
Stroke; 2023 Mar; 54(3):697-705. PubMed ID: 36734235
[TBL] [Abstract][Full Text] [Related]
11. Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Johnston SC; Amarenco P; Aunes M; Denison H; Evans SR; Himmelmann A; Jahreskog M; James S; Knutsson M; Ladenvall P; Molina CA; Nylander S; Röther J; Wang Y;
Stroke; 2021 Nov; 52(11):3482-3489. PubMed ID: 34477459
[TBL] [Abstract][Full Text] [Related]
12. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Shinohara Y; Katayama Y; Uchiyama S; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C;
Lancet Neurol; 2010 Oct; 9(10):959-68. PubMed ID: 20833591
[TBL] [Abstract][Full Text] [Related]
13. Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset.
Aoki J; Iguchi Y; Urabe T; Yamagami H; Todo K; Fujimoto S; Idomari K; Kaneko N; Iwanaga T; Terasaki T; Tanaka R; Yamamoto N; Tsujino A; Nomura K; Abe K; Uno M; Okada Y; Matsuoka H; Yamagata S; Yamamoto Y; Yonehara T; Inoue T; Yagita Y; Kimura K;
J Am Heart Assoc; 2019 Aug; 8(15):e012652. PubMed ID: 31347430
[TBL] [Abstract][Full Text] [Related]
14. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel-Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events.
Kalantzi K; Tentolouris N; Melidonis AJ; Papadaki S; Peroulis M; Amantos KA; Andreopoulos G; Bellos GI; Boutel D; Bristianou M; Chrisis D; Dimitsikoglou NA; Doupis J; Georgopoulou C; Gkintikas SA; Iraklianou S; Kanellas Κ; Kotsa K; Koufakis T; Kouroglou M; Koutsovasilis AG; Lanaras L; Liouri E; Lixouriotis C; Lykoudi A; Mandalaki E; Papageorgiou E; Papanas N; Rigas S; Stamatelatou MI; Triantafyllidis I; Trikkalinou A; Tsouka AN; Zacharopoulou O; Zoupas C; Tsolakis I; Tselepis AD
J Am Heart Assoc; 2021 Jan; 10(1):e018184. PubMed ID: 33327737
[TBL] [Abstract][Full Text] [Related]
16. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
[TBL] [Abstract][Full Text] [Related]
17. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
[TBL] [Abstract][Full Text] [Related]
18. Elevated Pulse Pressure and Recurrent Hemorrhagic Stroke Risk in Stroke With Cerebral Microbleeds or Intracerebral Hemorrhage.
Park JH; Lee J; Kwon SU; Sung Kwon H; Hwan Lee M; Kang DW
J Am Heart Assoc; 2022 Feb; 11(3):e022317. PubMed ID: 34779245
[TBL] [Abstract][Full Text] [Related]
19. Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).
Easton JD; Aunes M; Albers GW; Amarenco P; Bokelund-Singh S; Denison H; Evans SR; Held P; Jahreskog M; Jonasson J; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
Circulation; 2017 Sep; 136(10):907-916. PubMed ID: 28655834
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
